首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備 POC診斷

市場調查報告書

商品編碼

1467581

2024-2032 年照護端分子診斷市場報告（按產品和服務、技術、應用、最終用戶和地區分類）

Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023 年，全球護理IMARC Group分子診斷市場規模達到 37 億美元。

照護端 (POC) 分子診斷是指由醫生進行的用於診斷和檢測傳染病的測試。它包括血液學、懷孕、生育、傳染病、尿液分析檢測試劑盒以及心臟代謝和血糖監測設備。 POC 分子診斷廣泛用於識別傳染源、微小殘留疾病和胃腸道疾病，監測血紅蛋白和糞便潛血，以及確定患者代謝藥物或藥物類別的能力。這些測試提供更快的結果，減少與虐待相關的併發症，並改善感染控制措施。因此，POC 分子診斷在醫院、重症監護病房 (ICU)、研究機構、診所、分散式實驗室和家庭護理設施中得到廣泛應用。

照護端分子診斷市場趨勢：

全球傳染病的日益流行正在為市場創造積極的前景。 POC 分子診斷測試是一種經濟高效的解決方案，廣泛用於管理傳染病，如流感、結核病、人類免疫缺陷病毒 (HIV) 感染、衣原體和肝炎。此外，為了有效管理和控制 COVID-19 的傳播，對 PCR 檢測試劑盒的需求不斷成長，這是另一個成長誘導因素。此外，採用小型化、奈米技術和微流體技術來開發低成本、方便用戶使用且高靈敏度的分子診斷測試正在推動市場成長。此外，政府為改善醫療基礎設施和增強分子診斷能力而實施的各種措施正在對市場成長產生積極影響。其他因素，包括脫氧核糖核酸 (DNA) 定序的快速進步、對先進治療和診斷測試的認知不斷提高、老年人口的增加以及雲端連接 POC 診斷技術的最新發展，預計將推動市場成長。

本報告回答的關鍵問題

2023 年全球床邊分子診斷市場規模有多大？
2024-2032年全球照護端分子診斷市場的預期成長率為何？
推動全球照護端分子診斷市場的關鍵因素是什麼？
COVID-19 對全球照護端分子診斷市場有何影響？
基於產品和服務的全球照護端分子診斷市場的詳細情形如何？
基於此技術的全球照護端分子診斷市場的詳細情形如何？
基於應用的全球照護端分子診斷市場的詳細情形如何？
全球照護端分子診斷市場的關鍵區域有哪些？
全球照護端分子診斷市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- Becton Dickinson and Company
- Binx Health Inc.
- Co-Diagnostics Inc.
- F. Hoffmann-La Roche Ltd
- Gene STAT Molecular Diagnostics LLC
- Hemocue AB (Danaher Corporation)
- Meridian Bioscience Inc.
- Molbio Diagnostics Private Limited
- Quidel Corporation
- Siemens Healthcare GmbH (Siemens AG)
- Thermo Fisher Scientific Inc.
- Visby Medical Inc.

簡介目錄圖表

Product Code: SR112024A6271

The global point of care molecular diagnostics market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032.

Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.

Point of Care Molecular Diagnostics Market Trends:

The increasing prevalence of infectious diseases across the globe is creating a positive outlook for the market. POC molecular diagnostic tests is a cost-effective solution widely used to manage infectious diseases, such as flu, tuberculosis, human immunodeficiency virus (HIV) infection, chlamydia, and hepatitis. Additionally, the rising demand for PCR test kits to effectively manage and control the spread of COVID-19 is acting as another growth-inducing factor. Furthermore, the adoption of miniaturization, nanotechnology, and microfluidics to develop low-cost, user-friendly, and highly sensitive molecular diagnostic tests is providing an impetus to the market growth. Moreover, the implementation of various government initiatives toward improving healthcare infrastructure and enhancing molecular diagnostic capabilities is positively influencing the market growth. Other factors, including rapid advancements in deoxyribonucleic acid (DNA) sequencing, rising awareness regarding advanced therapeutic and diagnostic tests, increasing geriatric population, and recent developments in cloud-connected POC diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global point of care molecular diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and service, technology, application and end user.

Breakup by Product and Service:

Assays and Kits

Instruments and Analyzers

Software and Services

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Hybridization

DNA sequencing

Microarray

Isothermal Nucleic Acid Amplification Technology (INAAT)

Others

Breakup by Application:

Infectious Diseases

Oncology

Hematology

Prenatal Testing

Endocrinology

Others

Breakup by End User:

Physicians' Offices

Hospitals and ICUs

Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc. and Visby Medical Inc.

Key Questions Answered in This Report

1. What was the size of the global point of care molecular diagnostics market in 2023?
2. What is the expected growth rate of the global point of care molecular diagnostics market during 2024-2032?
3. What are the key factors driving the global point of care molecular diagnostics market?
4. What has been the impact of COVID-19 on the global point of care molecular diagnostics market?
5. What is the breakup of the global point of care molecular diagnostics market based on the product and service?
6. What is the breakup of the global point of care molecular diagnostics market based on the technology?
7. What is the breakup of the global point of care molecular diagnostics market based on application?
8. What are the key regions in the global point of care molecular diagnostics market?
9. Who are the key players/companies in the global point of care molecular diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Point of Care Molecular Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product and Service

6.1 Assays and kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Instruments and Analyzers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Polymerase Chain Reaction (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Hybridization
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 DNA sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Microarray
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Infectious Diseases
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Oncology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Hematology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Prenatal Testing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Endocrinology
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by End User

9.1 Physicians' Offices
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Hospitals and ICUs
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Becton Dickinson and Company
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Binx Health Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Co-Diagnostics Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 F. Hoffmann-La Roche Ltd
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
- 15.3.6 Gene STAT Molecular Diagnostics LLC
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Hemocue AB (Danaher Corporation)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Meridian Bioscience Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Molbio Diagnostics Private Limited
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Quidel Corporation
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Siemens Healthcare GmbH (Siemens AG)
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Thermo Fisher Scientific Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis
- 15.3.13 Visby Medical Inc.
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2023
Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2023
Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2023
Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2023
Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2023
Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2023
Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million US$), 2024-2032
Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219